Effects of Evolocumab on Low‐Density Lipoprotein Cholesterol, Non–High Density Lipoprotein Cholesterol, Apolipoprotein B, and Lipoprotein(a) by Race and Ethnicity: A Meta‐Analysis of Individual Participant Data From Double‐Blind and Open‐Label Extension Studies

BACKGROUND: Prevalence of cardiovascular disease risk factors and rates of atherosclerotic cardiovascular disease outcomes vary across racial/ethnic groups. This analysis examined the effects of evolocumab on LDL‐C (low‐density lipoprotein cholesterol) levels and LDL‐C goals achievement by race/ethn...

Descripción completa

Detalles Bibliográficos
Autores principales: Daviglus, Martha L., Ferdinand, Keith C., López, J. Antonio G., Wu, You, Monsalvo, Maria Laura, Rodriguez, Carlos J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Systematic Review and Meta‐analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955505/
https://www.ncbi.nlm.nih.gov/pubmed/33325247
http://dx.doi.org/10.1161/JAHA.120.016839

Ejemplares similares

Ejemplares similares